Telix Pharmaceuticals Ltd (TLX) KPIs and segments
Close on Nov 13, 2026Market cap $3.13BP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Telix Pharmaceuticals's business
Telix Pharmaceuticals's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q4 2025 | Q4 2024 |
|---|---|---|---|---|
Manufacturing Solutions($M) | 524 | 515 | 137 | |
Precision Medicine($M) | 323 | 233 | 301 | |
Therapeutics($M) | 233 | 228 | 134 | |
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-20.
See a number that looks wrong?